Emerald Health Therapeutics, Inc. (EMHTF)

0.37
OTC Markets
Prev Close 0.41
Day Low/High 0.36 / 0.44
52 Wk Low/High 0.40 / 3.49
Exchange OTC Markets
Shares Outstanding 146.47B
Market Cap 60.42M
Div & Yield N.A. (N.A)

Latest News

Village Farms Must Do Better Than This

Village Farms Must Do Better Than This

I'm not disappointed that Village Farms is raising money. I'm disappointed in how it transpired.

OTC Markets Group Launches OTCQX Cannabis Index

OTC Markets Group Launches OTCQX Cannabis Index

NEW YORK, June 4, 2019 /PRNewswire/ --  OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.

9 Speculative Plays for Investors Wanting Cannabis Exposure

9 Speculative Plays for Investors Wanting Cannabis Exposure

Five top marijuana stocks and four CBD plays in this speculative space.

Jefferies Analyst Rates Aurora Cannabis and 4 Other Pot Stocks as Buys

Jefferies Analyst Rates Aurora Cannabis and 4 Other Pot Stocks as Buys

Analyst Owen Bennett also says the market could rise to as high as $130 billion in 10 years.

Emerald Health Therapeutics Appoints Rebecca Wong As Vice President Quality Affairs

Emerald Health Therapeutics Appoints Rebecca Wong As Vice President Quality Affairs

Department head in quality assurance brings over 25 years' pharmaceutical, biotechnology, and medical device industry experience to lead Emerald quality affairs strategy

Emerald Health Therapeutics And Village Farms International Announce Cannabis Cultivation License For 1.1 Million Ft2 Delta 3 Greenhouse Operation

Emerald Health Therapeutics And Village Farms International Announce Cannabis Cultivation License For 1.1 Million Ft2 Delta 3 Greenhouse Operation

- Unmatched Experience and Expertise and Optimized Facility Design Will Support Continuous Production and Consistent Quality and Supply -

Emerald Health Therapeutics Named As #1 2018 TSX Venture 50™ Performer

Emerald Health Therapeutics Named As #1 2018 TSX Venture 50™ Performer

Emerald Achieves Top Performer Status in Clean Technology & Life Science Sector for 2nd Consecutive Year

Emerald Health Therapeutics Closes $18 Million Prospectus Sale

Emerald Health Therapeutics Closes $18 Million Prospectus Sale

Investor agrees to also exercise $18 million in additional warrants

Emerald Health Therapeutics And DMG Blockchain Solutions Establish LOI To Create Cannabis Supply Chain Management System And E-Commerce Platform

Emerald Health Therapeutics And DMG Blockchain Solutions Establish LOI To Create Cannabis Supply Chain Management System And E-Commerce Platform

Joint venture Cannachain Technologies would leverage blockchain technology designed to achieve unprecedented seed-to-sale provenance, safety and efficiency for the legal cannabis industry

Emerald Health Therapeutics Appoints Paul R. Dillman, Jr. To Vice President Of Sales And Marketing

Emerald Health Therapeutics Appoints Paul R. Dillman, Jr. To Vice President Of Sales And Marketing

Senior marketing executive with three decades global consumer packaged goods experience to lead Emerald's marketing and sales strategy

Northern Vine Labs Expands Dealer's License With Health Canada

Northern Vine Labs Expands Dealer's License With Health Canada

Amendment allows Northern Vine the ability to sell, transport and deliver cannabis under their licensed activities

Emerald Health Therapeutics Completes Investment In Licensed Dealer Northern Vine

Emerald Health Therapeutics Completes Investment In Licensed Dealer Northern Vine

Emerald and Abattis positioned to build analytical testing and import opportunities facilitated by dealer license, recently renewed by Health Canada

Emerald Health Therapeutics Announces Positive Health Canada Review Of Its Licensed Producer Application For Pure Sunfarms Facility

Emerald Health Therapeutics Announces Positive Health Canada Review Of Its Licensed Producer Application For Pure Sunfarms Facility

Conversion of First Quadrant of 1.1 Million Square Feet Greenhouse Facility Targeted for Completion in February 2018

Emerald Health Therapeutics To Acquire Control Of Licensed Dealer Northern Vine

Emerald Health Therapeutics To Acquire Control Of Licensed Dealer Northern Vine

Acquisition will expand Emerald's business to analytics services and creates strategic import/export and product development opportunities

Emerald Health's Two Cannabis Production Expansion Sites Progressing For Legalized Adult-Use Market In 2018

Emerald Health's Two Cannabis Production Expansion Sites Progressing For Legalized Adult-Use Market In 2018

Emerald submits applications to Health Canada for two significant production expansion projects, including one of Canada's largest-scale greenhouse operations

Emerald Health Therapeutics' Scientific Advisors Publish Research Discovery Of THCA Cannabinoid's Neuroprotective Treatment Potential

Emerald Health Therapeutics' Scientific Advisors Publish Research Discovery Of THCA Cannabinoid's Neuroprotective Treatment Potential

British Journal of Pharmacology highlights therapeutic potential of THCA, which Emerald is one of few Canadian licensed medical producers to produce and sell in current product line